{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:30:42Z","timestamp":1790944242117,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Shire International GmBH"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jhep.2020.03.024","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T23:07:12Z","timestamp":1585436832000},"page":"231-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study"],"prefix":"10.1016","volume":"73","author":[{"given":"Philip N.","family":"Newsome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Freilich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Y.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasim","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Sarles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Herring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvez","family":"Mantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeid","family":"Kayali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak-Myung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guruprasad P.","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.03.024_bib1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.024_bib2","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","article-title":"Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations","volume":"20","author":"Mili\u0107","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.03.024_bib3","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.03.024_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.03.024_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.024_bib6","first-page":"2714","article-title":"Nonalcoholic steatohepatitis: what we know in the new millennium","volume":"97","author":"Harrison","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.03.024_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.03.024_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.03.024_bib9","doi-asserted-by":"crossref","unstructured":"Banini B. Nonalcoholic steatohepatitis (NASH) has surpassed hepatitis C as the leading etiology for listing for liver transplant: implications for NASH in children and young adults. Presented at the American College of Gastroenterology 2016 Annual Scientific Meeting, 14\u201319 October 2016, Las Vegas, NV, USA.","DOI":"10.14309\/00000434-201610001-00755"},{"key":"10.1016\/j.jhep.2020.03.024_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.024_bib11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/apt.14210","article-title":"Review article: new treatments in non-alcoholic fatty liver disease","volume":"46","author":"Townsend","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.03.024_bib12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.024_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1037\/0003-066X.62.3.220","article-title":"Medicare's search for effective obesity treatments: diets are not the answer","volume":"62","author":"Mann","year":"2007","journal-title":"Am Psychol"},{"key":"10.1016\/j.jhep.2020.03.024_bib14","first-page":"37","article-title":"Long-term weight loss maintenance for obesity: a multidisciplinary approach","volume":"9","author":"Montesi","year":"2016","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jhep.2020.03.024_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhep.2020.03.024_bib16","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/s41598-017-05040-6","article-title":"Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice","volume":"7","author":"Tu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.03.024_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jhep.2020.03.024_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s13318-017-0429-7","article-title":"Absorption, distribution, metabolism, and excretion of [14C]-volixibat in healthy men: phase 1 open-label study","volume":"43","author":"Siebers","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jhep.2020.03.024_bib19","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2020.03.024_bib20","first-page":"407","article-title":"Intestinal bile acid transport: biology, physiology, and pathophysiology","volume":"32","author":"Shneider","year":"2001","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2020.03.024_bib21","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jhep.2020.03.024_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-14541-4_4","article-title":"Role of the intestinal bile acid transporters in bile acid and drug disposition","author":"Dawson","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jhep.2020.03.024_bib23","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/ajg.2011.162","article-title":"A\u00a0randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation","volume":"106","author":"Chey","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.03.024_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12872-015-0070-9","article-title":"Specific inhibition of bile acid transport alters plasma lipids and GLP-1","volume":"15","author":"Rudling","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jhep.2020.03.024_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.2011.04675.x","article-title":"Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation\u2013a double-blind study","volume":"34","author":"Simr\u00e9n","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.03.024_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12876-017-0736-0","article-title":"Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial","volume":"18","author":"Tiessen","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2020.03.024_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40360-018-0200-y","article-title":"A\u00a0randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis","volume":"19","author":"Palmer","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jhep.2020.03.024_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.024_bib29","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","article-title":"Bile acids as regulatory molecules","volume":"50","author":"Hylemon","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2020.03.024_bib30","doi-asserted-by":"crossref","first-page":"357ra122","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2020.03.024_bib31","doi-asserted-by":"crossref","first-page":"e0218459","DOI":"10.1371\/journal.pone.0218459","article-title":"Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-\/-.Leiden mice","volume":"14","author":"Salic","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.03.024_bib32","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.27973","article-title":"Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice","volume":"63","author":"Miethke","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.024_bib33","first-page":"205","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"57","author":"Prashanth","year":"2009","journal-title":"J\u00a0Assoc Physicians India"},{"key":"10.1016\/j.jhep.2020.03.024_bib34","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1478-3231.2011.02482.x","article-title":"Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors","volume":"31","author":"Leite","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.03.024_bib35","doi-asserted-by":"crossref","first-page":"8377","DOI":"10.3748\/wjg.v20.i26.8377","article-title":"Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment","volume":"20","author":"Leite","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.03.024_bib36","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.024_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.03.024_bib38","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/jat.3264","article-title":"Reconstituted high-density lipoprotein can elevate plasma alanine aminotransferase by transient depletion of hepatic cholesterol: role of the phospholipid component","volume":"36","author":"Herzog","year":"2016","journal-title":"J\u00a0Appl Toxicol"},{"key":"10.1016\/j.jhep.2020.03.024_bib39","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/gut.16.11.894","article-title":"Bile acids and colonic motility in the rabbit and the human","volume":"16","author":"Kirwan","year":"1975","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.03.024_bib40","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1172\/JCI106644","article-title":"Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man","volume":"50","author":"Mekjian","year":"1971","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2020.03.024_bib41","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820301860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820301860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:37:38Z","timestamp":1759174658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820301860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0168827820301860"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.03.024","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}